Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

XEN 45 Gel Stent: Long Term Performance and Safety Assessment (XEN LT)

NCT03868254 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT03868254
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03868254 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
XEN 45 Gel Stent: Long Term Performance and Safety Assessment (XEN LT)
Lead sponsor
Allergan
Phase
Observational
Overall status
Completed
Start date
April 5, 2019
Completion date
October 25, 2019
Enrollment
174 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma